GSK-649868

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-649868
Drug Alias NameGW-649868SB-649868GSK-649868
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor antagonists
TargetsOrexin receptor
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyGermanyUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A